Cargando…
Understanding heart failure with preserved ejection fraction: where are we today?
Heart failure with preserved ejection fraction (HFpEF) represents a complex and heterogeneous clinical syndrome, which is increasingly prevalent and associated with poor outcome. In contrast to heart failure with reduced ejection fraction (HFrEF), modern heart failure pharmacotherapy did not improve...
Autores principales: | van Heerebeek, L., Paulus, W. J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bohn Stafleu van Loghum
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4796052/ https://www.ncbi.nlm.nih.gov/pubmed/26909795 http://dx.doi.org/10.1007/s12471-016-0810-1 |
Ejemplares similares
-
Natriuretic Peptide Levels and Stages of Left Ventricular Dysfunction in Heart Failure with Preserved Ejection Fraction
por: Dal Canto, Elisa, et al.
Publicado: (2023) -
Stratified Treatment of Heart Failure with preserved Ejection Fraction: rationale and design of the STADIA‐HFpEF trial
por: Scheffer, Mariëlle, et al.
Publicado: (2020) -
Breakthrough in heart failure with preserved ejection fraction: are we there yet?
por: Lim, Shir Lynn, et al.
Publicado: (2016) -
Heart failure with preserved ejection fraction
por: Rigolli, Marzia, et al.
Publicado: (2013) -
Heart Failure With Preserved Ejection Fraction: An Evolving Understanding
por: Tah, Sunanda, et al.
Publicado: (2023)